Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2008 September;33(3) > Minerva Endocrinologica 2008 September;33(3):175-91

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ENDOCRINOLOGICA

A Journal on Endocrine System Diseases


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,118


eTOC

 

REVIEWS  


Minerva Endocrinologica 2008 September;33(3):175-91

language: English

Scintigraphic imaging of adrenal disease

Gross M. D. 1, Wong K. K. 1, Rubello D. 2

1 Nuclear Medicine Service, Department of Veterans Affairs Health System and Division of Nuclear Medicine, Department of Radiology, University of Michigan Medical School, Ann Arbor, MI, USA
2 Nuclear Medicine Service PET Unit, S. Maria della Misericordia Rovigo Hospital, Istituto Oncologico Veneto (IOV), Rovigo, Italy


PDF  


The nuclear medicine approach to adrenal imaging spans six decades with radiopharmaceuticals designed to take advantage of the unique characteristics of the functional divisions of the gland, substrate accumulation, hormone biosynthesis, receptor-ligand interactions and pharmacologic manipulation of mechanisms of central control. The recent introduction of hybrid imaging techniques that combine high resolution anatomy with the functional maps derived from the scintigraphic images is yet another step in the evolution of integrated imaging techniques that can be used to diagnostic advantage in the evaluation of disease of the adrenal gland.

top of page

Publication History

Cite this article as

Corresponding author e-mail